Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10918006 | Radiotherapy and Oncology | 2014 | 6 Pages |
Abstract
Our results indicate that, instead of using the FAZA-BL scan as the basis for the dose escalation, FAZA-W2 of CHRT is most suitable and might provide a more reliable basis for the integration of 18F-FAZA-PET/CT information into radiotherapy treatment planning for hypoxia-directed dose escalation strategies.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Vikram R. Bollineni, Michel J.B. Koole, Jan Pruim, Charlotte L. Brouwer, Erwin M. Wiegman, Harry J.M. Groen, Renske Vlasman, Gyorgy B. Halmos, Sjoukje F. Oosting, Johannes A. Langendijk, Joachim Widder, Roel J.H.M. Steenbakkers,